Search results
Roche's (RHHBY) Ocrevus Subcutaneous Gets European Commission Nod
Zacks via Yahoo News· 2 weeks agoRoche (RHHBY) obtains approval for the subcutaneous formulation of relapsing multiple sclerosis drug...
Pharma Stock Roundup: FDA Nod to MRK's New Jab & Expanded Use of ABBV & AZN Drugs
Zacks via Yahoo News· 3 weeks agoFDA approves Merck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive and the expanded use...
Street Fighter VI Devs Talk About Monetization, M. Bison, And The Series' First-Ever Guest Fighter
Kotaku via Yahoo News· 3 weeks agoIt’s hard to believe that the most famous franchise in fighting game history has never had a guest...
AstraZeneca's (AZN) Imfinzi Gets FDA Nod in Expanded Use
Zacks via Yahoo News· 3 weeks agoThe FDA approves AstraZeneca's (AZN) Imfinzi in combination with chemotherapy for treating mismatch...
5 Growth Stocks to Buy for Steady Returns in June
Zacks via Yahoo News· 1 month agoWall Street’s popular adages are not matching this year. April is historically known for being favorable to investors. But this year, April ended on a...
I Apparently Inspired a Scene in A Million Little Things’ Series Finale — Watch How I Found Out
TVLine.com via Yahoo News· 1 month agoBefore last weekend, I had no idea that Gary Mendez’s death and my mom’s had anything to do with...
Why Is Prothena (PRTA) Down 1.5% Since Last Earnings Report?
Zacks via Yahoo News· 1 month agoA month has gone by since the last earnings report for Prothena (PRTA). Shares have lost about 1.5%...
Top 5 Non-Tech Winners YTD With More Potential for Growth
Zacks via Yahoo News· 1 month agoFive Nasdaq listed non-tech stocks that have provided more than 40% returns year to date and have...
J&J's (JNJ) Oral Pill Improves Depression & Insomnia Symptoms
Zacks via Yahoo News· 1 month agoData from a late-stage study shows that treatment with J&J's (JNJ) experimental drug met all study...
Candel (CADL) Stock Skyrockets 431% Year to Date: Here's Why
Zacks via Yahoo News· 1 month agoCandel (CADL) surges 431% in the year-to-date period, driven by positive developmental and...